Uncategorized First-in-human application of double-stranded RNA bacteriophage 20 Jan 2023 Publication: Brief Report - "First-in-human application of double-stranded RNA bacteriophage in the treatment of pulmonary Pseudomonas aeruginosa infection" by Li et al. https://doi.org/10.1111/1751-7915.14217 Abstract A double-stranded RNA (dsRNA) phage phiYY is able…
Uncategorized Adaptive Phage Therapeutics Announces First Patient Dosed in the PHAGE Clinical Trial 18 Jan 2023 Adaptive Phage Therapeutics, Inc., (APT) a clinical-stage biotechnology company advancing the APT phage bank, the world’s largest therapeutic phage initiative for treatment of bacterial infectious diseases, today announced the first…
Uncategorized Are bacteriophages the new antibiotics? 4 Jan 2023 Bacteriophages, viruses that infect bacteria, may be used as an alternative treatment option when antibiotics fail. Leiden researchers have studied the structure and function of a novel bacteriophage that could…
Uncategorized New Year; New Role; New Beginning… 4 Jan 2023 Excited!!! Starting a new position as a "Postdoctoral Research Associate" (in NIH project) at the Center for Phage Technology (Young lab), Department of Biochemistry and Biophysics, Texas A&M AgriLife Research,…
Uncategorized Use of bacteria-killing viruses to treat infection, UK 3 Dec 2022 Bacteriophages, also known as phages, are viruses that infect and can kill bacteria. They hold promise in treating drug-resistant infections, which are on the rise globally and are estimated to…
Uncategorized Synthetic engineering and biological containment of bacteriophages 27 Nov 2022 Abstract The serious threats posed by drug-resistant bacterial infections and recent developments in synthetic biology have fueled a growing interest in genetically engineered phages with therapeutic potential. To date, many…
Uncategorized Efficacy of phage therapy in preclinical models 14 Nov 2022 Efficacy of phage therapy in preclinical models of bacterial infection: a systematic review and meta-analysis Published: November 09, 2022, DOI: https://doi.org/10.1016/S2666-5247(22)00288-9 Summary Background Antimicrobial resistance of bacterial pathogens is an…
Uncategorized Global Demand for Bacteriophage Market is Expected to Witness Growth at 4.2% CAGR 11 Nov 2022 Russia is set to exhibit a CAGR of 5.8% in Europe bacteriophage market during the forecast period. Sales of bacteriophage in Australia are projected to increase at a CAGR rate…
Uncategorized Latest in Phage Engineering 3 Nov 2022 Bacteriophage genome engineering with CRISPR–Cas13a https://www.nature.com/articles/s41564-022-01243-4 Abstract Jumbo phages such as Pseudomonas aeruginosa ФKZ have potential as antimicrobials and as a model for uncovering basic phage biology. Both pursuits are currently limited…
